These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7000694)

  • 1. Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes.
    Baltz ML; Dyck RF; Pepys MB
    Immunology; 1980 Sep; 41(1):59-66. PubMed ID: 7000694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine amyloid protein AA in casein-induced experimental amyloidosis.
    Skinner M; Shirahama T; Benson MD; Cohen AS
    Lab Invest; 1977 Apr; 36(4):420-7. PubMed ID: 403374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin biosynthesis in myeloma-associated and casein- and endotoxin-induced murine amyloidosis.
    Baumal R; Ackermann A; Wilson B
    J Immunol; 1975 Jun; 114(6):1785-91. PubMed ID: 1092761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
    Miura K; Takahashi Y; Shirasawa H
    Lab Invest; 1985 Oct; 53(4):453-63. PubMed ID: 3900582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.
    Baltz ML; Caspi D; Evans DJ; Rowe IF; Hind CR; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):691-700. PubMed ID: 3568456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains.
    Baltz ML; Gomer K; Davies AJ; Evans DJ; Klaus GG; Pepys MB
    Clin Exp Immunol; 1980 Feb; 39(2):355-60. PubMed ID: 7389204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of amyloid in murine and human secondary amyloidosis by the immunoperoxidase technique.
    Livni N; Laufer A; Levo Y
    J Pathol; 1980 Dec; 132(4):343-8. PubMed ID: 7003080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further characterization of amyloid-enhancing factor.
    Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
    Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
    Benson MD; Kleiner E
    J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
    Gonnerman WA; Kandel R; Cathcart ES
    Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of amyloidosis by syngeneic spleen cells from normal donors.
    Axelrad M; Kisilevsky R; Beswetherick S
    Am J Pathol; 1975 Feb; 78(2):277-84. PubMed ID: 1115221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
    Snow AD; Kisilevsky R
    Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental murine amyloidosis: a model system for studying amyloid formation.
    Baumal R; Wilson B; Pass E
    Can Med Assoc J; 1975 Sep; 113(6):512-6. PubMed ID: 1080430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amyloid transfer from a syngenous transplant of amyloid spleen in intact and amyloid mice].
    Sura VV; Osipova IN; Chebyshev AP; Serov VV; Gritsman AIu
    Biull Eksp Biol Med; 1978 Jun; 85(6):754-7. PubMed ID: 667351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects.
    Scheinberg MA; Cathcart ES; Eastcott JW; Skinner M; Benson M; Shirahama T
    Lab Invest; 1976 Jul; 35(1):47-54. PubMed ID: 781403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid resistance in A/J mice. Studies with a transfer model.
    Wohlgethan JR; Cathcart ES
    Lab Invest; 1980 Jun; 42(6):663-7. PubMed ID: 7392571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphologic study of the early stages of amyloidogenesis].
    Kapinus LN
    Biull Eksp Biol Med; 1978 Feb; 85(2):232-4. PubMed ID: 343835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine alveolar hydatidosis: a potential experimental model for the study of AA-amyloidosis.
    Ali-Khan Z; Jothy S; Al-Karmi T
    Br J Exp Pathol; 1983 Dec; 64(6):599-611. PubMed ID: 6661394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic demonstration of cytoplasmic ASSAM-related antigenic substance (CASSAM) by an immunoperoxidase technique.
    Takeshita S; Higuchi K; Hosokawa M; Matsumura A; Higuchi K; Kohno A; Matsushita M; Yonezu T; Takeda T
    Am J Pathol; 1985 Dec; 121(3):455-65. PubMed ID: 3907365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.